- US-listed companies
- Bellerophon Therapeutics, Inc.
- Income statement
Bellerophon Therapeutics, Inc.BLPH
Market cap
$146.79K
P/E ratio
| 2015/12 | 2016/12 | 2017/12 | 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | |
| Operating income | -47 | -24 | -25 | -28 | -17 | -26 | - | - |
| Operating expenses | 48 | 24 | 25 | 28 | 17 | 26 | - | - |
| Income before tax | -46 | -24 | -55 | -3 | -15 | -27 | - | - |
| Provision for income taxes | - | -0 | - | -5 | -2 | -2 | - | - |
| Effective tax rate (%) | - | - | - | - | ||||
| Net income | - | - | -55 | 3 | -13 | -25 | -18 | -20 |
| Earnings per share | - | - | - | 0.05 | -2.95 | -3.17 | - | - |
| Diluted EPS | - | - | - | -0.34 | -2.95 | -3.17 | - | - |